Debbie joined CellCentric in September 2021.
Debbie received her bachelor’s degree in Anatomical Sciences from Manchester University in 1993. Following a number of roles in Regulatory Affairs at Elan, Daiichi, Dainippon Sumitomo and Johnson and Johnson, Debbie went on to serve as the regional head of Europe, Middle East and Africa for Genentech UK Ltd.’s Office of International Development. Most recently, Debbie was Vice President Clinical Development and Regulatory for Sarah Cannon, the cancer focused CRO based in Nashville.
Debbie has more than 24 years of drug development experience obtained from working in the pharma/biotech, CRO and hospital sectors. One of her primary areas of expertise is regulatory affairs, including non-clinical and clinical development planning and regulatory strategy however, she also has experience of managing personalized medicine, drug safety, quality assurance and training and process improvement teams. She has built multiple collaborative relationships with pharma/biotech, NHS hospitals and academia, and was instrumental in establishing Sarah Cannon’s personalized medicine business in the US and UK.